drugset / Trial / NCT05045781
Safety, Tolerability and Pharmacokinetics of Eptinezumab in Healthy Chinese Subjects
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate how the body absorbs and get rid of eptinezumab when given directly into a vein in Chinese subjects.
Timeline
- Start
- 2021-04-20
- Primary completion
- 2021-07-20
- Completion
- 2021-07-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eptinezumab | Monoclonal antibody | 100 mg | Intravenous |
| Subject | Eptinezumab | Monoclonal antibody | 300 mg | Intravenous |
Indications
No indication recorded.